Revolution Medicines
(NASDAQ) RVMD
Revolution Medicines Financials at a Glance
Market Cap
$30.97B
Revenue (TTM)
$0.00
Net Income (TTM)
$1.37B
EPS (TTM)
$-7.07
P/E Ratio
-20.59
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$145.59
Volume
922.011
Open
$147.84
Price
$145.59
Volume
922.011
Open
$147.84
Previous Close
$145.66
Daily Range
$141.25 - $148.85
52-Week Range
$34.00 - $155.70
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$145.59
Volume
922.011
Open
$147.84
Previous Close
$145.66
Daily Range
$141.25 - $148.85
52-Week Range
$34.00 - $155.70
RVMD News
RVMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Revolution Medicines
Industry
Biotechnology
Sector
Health CareEmployees
883
CEO
Mark A. Goldsmith, MD, PhD
Website
www.revmed.comHeadquarters
Redwood City, CA 94063, US
RVMD Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-77%
Return on Capital
-71%
Return on Assets
-61%
Earnings Yield
-4.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$30.97B
Shares Outstanding
212.60M
Volume
922.011
Avg. Volume
2.91M
Financials (TTM)
Gross Profit
$16.56M
Operating Income
$1.18B
EBITDA
$1.09B
Operating Cash Flow
$897.74M
Capital Expenditure
$15.99M
Free Cash Flow
$913.73M
Cash & ST Invst.
$2.03B
Total Debt
$158.70M
Revolution Medicines Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.54M
N/A
Gross Margin
0.00%
N/A
Market Cap
$30.97B
N/A
Market Cap/Employee
$50.27M
N/A
Employees
616
N/A
Net Income
$453.82M
-112.6%
EBITDA
$440.69M
-85.9%
Quarterly Fundamentals
Net Cash
$1.75B
-11.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$140.02M
+15.4%
Short Term Debt
$16.61M
+28.0%
Return on Assets
-60.86%
N/A
Return on Invested Capital
-70.61%
N/A
Free Cash Flow
$355.70M
-79.9%
Operating Cash Flow
$354.17M
-82.2%